CEO Andrew Witty is reported to have received an 11.9% pay increase to remain among the highest-paid CEOs of U.S.-listed health insurers in 2024, according to an S&P Global Market Intelligence analysis.

With the recent slide, UnitedHealth Group's stock price has fallen 53.1% over the past three years through Aug. 5. The company does pay dividends, which it has increased during this time. When factoring in these payments, the shares have a total return of negative 50.8%.

UnitedHealth Group CEO Andrew Witty is stepping down and the healthcare giant says it's suspending its full-year forecast due to higher-than-expected medical costs.

The company may be under criminal investigation for alleged irregularities in its Medicare business—but it's been touched by the Warren Buffett effect.

UnitedHealth Group is a dividend growth stalwart much in line with Berkshire's history of interest in insurance investments. Investors are not being foolhardy in the hope that Berkshire continues buying while UNH trades at 50% off its all-time high of $630.

UnitedHealth Group's 2024 revenues hit $400.3 billion in 2024 – a 6% year-over-year increase – and full-year earnings from operations were $32.3 billion. CEO Andrew Witty attributed much of this performance to a strong showing from pharmacy benefit manager OptumRx.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.

Shares of UnitedHealth Group are surging before the market open Friday as Warren Buffett’s Berkshire Hathaway disclosed that it recently purchased shares of the beleaguered insurer

UnitedHealth Group said on Thursday it will replace its finance chief John Rex with an external hire, Wayne DeVeydt, adding to the management changes at the health insurer that has been struggling to control its medical costs.

Silverman's complaint accuses UnitedHealth's leadership, including CEO Stephen Hemsley, former CEO Andrew Witty and several board members, of: Breaching their fiduciary duties